BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9569200)

  • 1. Rap1b association with the platelet cytoskeleton occurs in the absence of glycoproteins IIb/IIIa.
    White GC; Fischer TH; Duffy CM
    Thromb Haemost; 1998 Apr; 79(4):832-6. PubMed ID: 9569200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa.
    Holme PA; Solum NO; Brosstad F; Egberg N; Lindahl TL
    Thromb Haemost; 1995 Dec; 74(6):1533-40. PubMed ID: 8772233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Talin does not associate exclusively with alpha 2b beta 3 integrin in activated human platelets.
    Escolar G; Diaz-Ricart M; White JG
    J Lab Clin Med; 1995 May; 125(5):597-607. PubMed ID: 7537787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD63 associates with the alphaIIb beta3 integrin-CD9 complex on the surface of activated platelets.
    Israels SJ; McMillan-Ward EM; Easton J; Robertson C; McNicol A
    Thromb Haemost; 2001 Jan; 85(1):134-41. PubMed ID: 11204565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY; Wu YC; Wu CC
    Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fc receptor-dependent platelet activation results independently of glycoprotein complex IIb/IIIa].
    Greinacher A; Liebenhoff U; Kiefel V; Presek P; Mueller-Eckhardt C
    Beitr Infusionsther Transfusionsmed; 1994; 32():208-10. PubMed ID: 9480089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
    Nurden AT; Rosa JP; Fournier D; Legrand C; Didry D; Parquet A; Pidard D
    J Clin Invest; 1987 Mar; 79(3):962-9. PubMed ID: 3818957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of the platelet surface area and surface density of glycoprotein IIb-IIIa of unactivated human platelets of various sizes.
    Leytin V; Shapiro H; Novikov I; Radnay J
    Biochem Biophys Res Commun; 1996 Sep; 226(1):94-100. PubMed ID: 8806597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD36 is spatially associated with glycoprotein IIb-IIIa (alpha IIb beta 3) on the surface of resting platelets.
    Dorahy DJ; Berndt MC; Shafren DR; Burns GF
    Biochem Biophys Res Commun; 1996 Jan; 218(2):575-81. PubMed ID: 8561798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.
    Pearce AC; Wonerow P; Marshall SJ; Frampton J; Gartner TK; Watson SP
    Biochem J; 2004 Feb; 378(Pt 1):193-9. PubMed ID: 14558887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence for the interaction of platelet surface membrane proteins GPIIb and III with cytoskeletal components: protein crosslinking studies.
    Painter RG; Gaarde W; Ginsberg MH
    J Cell Biochem; 1985; 27(3):277-90. PubMed ID: 3157694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
    Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet integrin alpha IIb beta 3 (GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets.
    Pedreño J; Fernández R; Cullaré C; Barceló A; Elorza MA; de Castellarnau C
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):156-63. PubMed ID: 9012651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glanzmann's thrombasthenia: updated.
    Nair S; Ghosh K; Kulkarni B; Shetty S; Mohanty D
    Platelets; 2002 Nov; 13(7):387-93. PubMed ID: 12487785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reassociation and translocation of glycoprotein IIB-IIIA in EDTA-treated human platelets.
    Ma Y; Wong K
    Platelets; 2007 Sep; 18(6):451-9. PubMed ID: 17763154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the selective association of a subpopulation of GPIIb-IIIa with the actin cytoskeletons of thrombin-activated platelets.
    Bertagnolli ME; Beckerle MC
    J Cell Biol; 1993 Jun; 121(6):1329-42. PubMed ID: 8509453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein IIb-IIIa and the translocation of Rap2B to the platelet cytoskeleton.
    Torti M; Ramaschi G; Sinigaglia F; Lapetina EG; Balduini C
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4239-43. PubMed ID: 8183895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoskeletal interactions of Rap1b in platelets.
    White GC; Crawford N; Fischer TH
    Adv Exp Med Biol; 1993; 344():187-94. PubMed ID: 8209787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ex vivo production of human monoclonal antibodies to glycoprotein IIb-IIIa complexes of blood platelets.
    Laroche-Traineau J; Clofent-Sanchez G; Vezon G; Nurden AT
    Hum Antibodies Hybridomas; 1994; 5(3-4):165-77. PubMed ID: 7538808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.